Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Le Zhao

Showing results (441-450 of 448) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 448 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 27, 2023
Significant Unconventional Anomalous Hall Effect in Heavy Metal/Antiferromagnetic Insulator HeterostructuresYuhan Liang, Liang Wu, Minyi Dai, et al.
Oncotarget|July 1, 2015
High EGFR and low p-Akt expression is associated with better outcome after nimotuzumab-containing treatment in esophageal cancer patients: preliminary clinical result and testable hypothesisChun-yu Wang, Jia-ying Deng, Xu-wei Cai, et al.
Radiation Oncology (London, England)|September 28, 2024
Dose escalation in radical radio(chemo)therapy for cervical and upper thoracic esophageal cancer with 3DCRT/IMRT (ChC&UES): a multicenter retrospective studyXiao-Han Zhao, Wen-Cheng Zhang, Xin Wang, et al.
Msystems|January 23, 2020
Impacts of the Plateau Environment on the Gut Microbiota and Blood Clinical Indexes in Han and Tibetan IndividualsZhilong Jia, Xiaojing Zhao, Xiaoshuang Liu, et al.
Nature Chemistry|September 25, 2019
Fungal indole alkaloid biogenesis through evolution of a bifunctional reductase/Diels-AlderaseQingyun Dan, Sean A Newmister, Kimberly R Klas, et al.
Journal of Medicinal Chemistry|May 27, 2026
Discovery of Dual A<sub>2A</sub>/A<sub>2B</sub> Adenosine Receptor Antagonist and Clinical Candidate INCB106385Chao Qi, Matthew S McCammant, Yong Li, et al.
Nature Ecology & Evolution|February 28, 2025
Genomic and phenotypic evidence support visual and olfactory shifts in primate evolutionHai Chi, Jiahui Wan, Amanda D Melin, et al.
Journal of Medicinal Chemistry|January 8, 2025
Discovery of INCB159020, an Orally Bioavailable KRAS G12D InhibitorQinda Ye, Artem Shvartsbart, Zhenwu Li, et al.
Pageof 45

Showing results (441-450 of 448) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 448 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 27, 2023
Significant Unconventional Anomalous Hall Effect in Heavy Metal/Antiferromagnetic Insulator HeterostructuresYuhan Liang, Liang Wu, Minyi Dai, et al.
Oncotarget|July 1, 2015
High EGFR and low p-Akt expression is associated with better outcome after nimotuzumab-containing treatment in esophageal cancer patients: preliminary clinical result and testable hypothesisChun-yu Wang, Jia-ying Deng, Xu-wei Cai, et al.
Radiation Oncology (London, England)|September 28, 2024
Dose escalation in radical radio(chemo)therapy for cervical and upper thoracic esophageal cancer with 3DCRT/IMRT (ChC&UES): a multicenter retrospective studyXiao-Han Zhao, Wen-Cheng Zhang, Xin Wang, et al.
Msystems|January 23, 2020
Impacts of the Plateau Environment on the Gut Microbiota and Blood Clinical Indexes in Han and Tibetan IndividualsZhilong Jia, Xiaojing Zhao, Xiaoshuang Liu, et al.
Nature Chemistry|September 25, 2019
Fungal indole alkaloid biogenesis through evolution of a bifunctional reductase/Diels-AlderaseQingyun Dan, Sean A Newmister, Kimberly R Klas, et al.
Journal of Medicinal Chemistry|May 27, 2026
Discovery of Dual A<sub>2A</sub>/A<sub>2B</sub> Adenosine Receptor Antagonist and Clinical Candidate INCB106385Chao Qi, Matthew S McCammant, Yong Li, et al.
Nature Ecology & Evolution|February 28, 2025
Genomic and phenotypic evidence support visual and olfactory shifts in primate evolutionHai Chi, Jiahui Wan, Amanda D Melin, et al.
Journal of Medicinal Chemistry|January 8, 2025
Discovery of INCB159020, an Orally Bioavailable KRAS G12D InhibitorQinda Ye, Artem Shvartsbart, Zhenwu Li, et al.
Pageof 45